Retrospective Study
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Oct 24, 2022; 13(10): 802-812
Published online Oct 24, 2022. doi: 10.5306/wjco.v13.i10.802
Oncology and reproductive outcomes over 16 years of malignant ovarian germ cell tumors treated by fertility sparing surgery
Muangloei Rungoutok, Prapaporn Suprasert
Muangloei Rungoutok, Prapaporn Suprasert, Department of Obstetrics and Gynecology, Chiang Mai University, Muang 50200, Chiang Mai, Thailand
Author contributions: Rungoutok M and Suprasert P contributed equally to this work; Suprasert P designed the research study; Rungoutok M and Suprasert P performed the research and contributed analytic tools; Suprasert P analyzed the data and wrote the manuscript; all authors have read and approved the final manuscript.
Institutional review board statement: The study was approved by Chiang Mai University Ethic Committees (Research ID: 7736; Study Code: OBG-2563-07736).
Informed consent statement: Patients were not required to give informed consent for the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: All authors declare no potential conflict of interest for the article.
Data sharing statement: Technical appendix, statistical code, and dataset available from the corresponding author at psuprase@gmail.com. Participants consent was not obtained but the presented data are anonymized and risk of identification is low.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Prapaporn Suprasert, MD, Associate Professor, Department of Obstetrics and Gynecology, Chiang Mai University, 110 Inthawarorod Road, Muang 50200, Chiang Mai, Thailand. psuprase@gmail.com
Received: July 7, 2022
Peer-review started: July 7, 2022
First decision: August 22, 2022
Revised: August 26, 2022
Accepted: September 9, 2022
Article in press: September 9, 2022
Published online: October 24, 2022
Processing time: 104 Days and 21.4 Hours
Core Tip

Core Tip: The oncology and reproductive outcomes of malignant ovarian germ cell tumors treated by fertility-sparing surgery were satisfying. Even though most patients developed normal menstruation, nearly 1/3 were successfully pregnant and delivered.